awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35020443-3B310AC5-4D68-4FF8-AA9F-A5AC57B72AC9
Q35020443-3B310AC5-4D68-4FF8-AA9F-A5AC57B72AC9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35020443-3B310AC5-4D68-4FF8-AA9F-A5AC57B72AC9
Breakthrough cancer medicine and its impact on novel drug development in China: report of the US Chinese Anti-Cancer Association (USCACA) and Chinese Society of Clinical Oncology (CSCO) Joint Session at the 17th CSCO Annual Meeting.
P2860
Q35020443-3B310AC5-4D68-4FF8-AA9F-A5AC57B72AC9
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35020443-3B310AC5-4D68-4FF8-AA9F-A5AC57B72AC9
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
3b435e3f9d2d373126cfce49193cfd63739f1a8d
P2860
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies.